Clinical Features of Herpes Simplex Keratitis in a Korean Tertiary Referral Center: Efficacy of Oral Antiviral and Ascorbic Acid on Recurrence
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose: To describe the clinical manifestations of herpes simplex keratitis (HSK) in a tertiary referral center in South Korea and to determine whether ascorbic acid treatment prevents recurrence of herpetic epithelial keratitis. Methods: This retrospective cohort study included all consecutive patients with herpetic keratitis referred to our center from January 2010 to January 2015. Clinical features, ocular complications, and recurrences were recorded. Results: In total, 149 eyes of the 133 patients (72 male and 61 female) were followed for an average of 24.6 ± 13.2 months. Sixteen (12.0%) patients had bilateral HSK. The most frequent HSK subtype was epithelial keratitis (49.7%), which was followed by stromal keratitis (23.5%). Epithelial keratitis was the most likely subtype to recur. Complications occurred in 122 (81.9%) eyes. The most common complication was corneal opacity. Recurrences were observed in 48 (32.2%) eyes. The recurrence rates were lower in the prophylactic oral antiviral agent group (16 / 48 eyes, 33.3% vs. 49 / 101 eyes, 48.5%) and the ascorbic acid treatment group (13 / 48 eyes, 27.1% vs. 81 / 101 eyes, 70.3%) compared with the groups without medications. Univariate logistic regression analysis revealed that both factors significantly reduced the risk of recurrence (acyclovir: odds ratio, 0.25; 95% confidence intervals, 0.12 to 0.51; ascorbic acid: odds ratio, 0.51; 95% confidence intervals, 0.20 to 0.91). Conclusions: This retrospective study described the clinical findings of HSK in a tertiary referral center in South Korea. Prophylactic oral antiviral agent treatment and oral ascorbic acid administration may lower the risk of recurrence.
Abstract
Purpose: To describe the clinical manifestations of herpes simplex keratitis (HSK) in a tertiary referral center in South Korea and to determine whether ascorbic acid treatment prevents recurrence of herpetic epithelial keratitis. Methods: This retrospective cohort study included all consecutive patients with herpetic keratitis referred to our center from January 2010 to January 2015. Clinical features, ocular complications, and recurrences were recorded. Results: In total, 149 eyes of the 133 patients (72 male and 61 female) were followed for an average of 24.6 ± 13.2 months. Sixteen (12.0%) patients had bilateral HSK. The most frequent HSK subtype was epithelial keratitis (49.7%), which was followed by stromal keratitis (23.5%). Epithelial keratitis was the most likely subtype to recur. Complications occurred in 122 (81.9%) eyes. The most common complication was corneal opacity. Recurrences were observed in 48 (32.2%) eyes. The recurrence rates were lower in the prophylactic oral antiviral agent group (16 / 48 eyes, 33.3% vs. 49 / 101 eyes, 48.5%) and the ascorbic acid treatment group (13 / 48 eyes, 27.1% vs. 81 / 101 eyes, 70.3%) compared with the groups without medications. Univariate logistic regression analysis revealed that both factors significantly reduced the risk of recurrence (acyclovir: odds ratio, 0.25; 95% confidence intervals, 0.12 to 0.51; ascorbic acid: odds ratio, 0.51; 95% confidence intervals, 0.20 to 0.91). Conclusions: This retrospective study described the clinical findings of HSK in a tertiary referral center in South Korea. Prophylactic oral antiviral agent treatment and oral ascorbic acid administration may lower the risk of recurrence.
참고문헌 (21)
- Liesegang TJ, "Herpes simplex virus epidemiology and ocular importance", Cornea, 20, pp.1~13 (2001)[DOI]
- Liesegang TJ, "Epidemiology of ocular herpes simplex: incidence in Rochester, Minn, 1950 through 1982", Arch Ophthalmol, 107, pp.1155~1159 (1989)[DOI]
- Kaye S, "Herpes simplex keratitis", Prog Retin Eye Res, 25, pp.355~380 (2006)[DOI]
- "A controlled trial of oral acyclovir for iridocyclitis caused by herpes simplex virus. The Herpetic Eye Disease Study Group", Arch Ophthalmol, 114, pp.1065~1072 (1996)[DOI]
- Schwartz GS, "Oral acyclovir for the management of herpes simplex virus keratitis in children", Ophthalmology, 107, pp.278~282 (2000)[DOI]
- Lee GU, "Corticosteroid therapy in herpes simplex virus keratitis", J Korean Ophthalmol Soc, 27, pp.493~496 (1986)
- "A controlled trial of oral acyclovir for the prevention of stromal keratitis or iritis in patients with herpes simplex virus epithelial keratitis. The Epithelial Keratitis Trial. The Herpetic Eye Disease Study Group", Arch Ophthalmol, 115, pp.703~712 (1997)[DOI]
- "Acyclovir for the prevention of recurrent herpes simplex virus eye disease. Herpetic Eye Disease Study Group", N Engl J Med, 339, pp.300~306 (1998)[DOI]
- "Oral acyclovir for herpes simplex virus eye disease: effect on prevention of epithelial keratitis and stromal keratitis. Herpetic Eye Disease Study Group", Arch Ophthalmol, 118, pp.1030~1036 (2000)[DOI]
- Sudesh S, "The impact of the herpetic eye disease studies on the management of herpes simplex virus ocular infections", Curr Opin Ophthalmol, 10, pp.230~233 (1999)[DOI]
- Cho YW, "Efficacy of systemic vitamin C supplementation in reducing corneal opacity resulting from infectious keratitis", Medicine (Baltimore), 93, pp.e125~ (2014)[DOI]
- Yoon JC, "Antiviral activity of ascorbic acid against herpes simplex virus", J Korean Soc Microbiol, 35, pp.1~8 (2000)
- Terezhalmy GT, "The use of water-soluble bioflavonoid-ascorbic acid complex in the treatment of recurrent herpes labialis", Oral Surg Oral Med Oral Pathol, 45, pp.56~62 (1978)[DOI]
- Labetoulle M, "Incidence of herpes simplex virus keratitis in France", Ophthalmology, 112, pp.888~895 (2005)[DOI]
- 황준서, "한국인 단순포진각막염 환자의 임상 분석", 대한안과학회지, 48(9), pp.1212~1219 (2007), 대한안과학회
- Miserocchi E, "Clinical features of ocular herpetic infection in an italian referral center", Cornea, 33, pp.565~570 (2014)[DOI]
- Shuster JJ, "Statistical analysis of the rate of recurrence of herpesvirus ocular epithelial disease", Am J Ophthalmol, 91, pp.328~331 (1981)[DOI]
- "Predictors of recurrent herpes simplex virus keratitis. Herpetic Eye Disease Study Group", Cornea, 20, pp.123~128 (2001)[DOI]
- Brinkevich SD, "Radical-regulating and antiviral properties of ascorbic acid and its derivatives", Bioorg Med Chem Lett, 22, pp.2424~2427 (2012)[DOI]
- Furuya A, "Antiviral effects of ascorbic and dehydroascorbic acids in vitro", Int J Mol Med, 22, pp.541~545 (2008)
- Hah YS, "Ascorbic acid concentrations in aqueous humor after systemic vitamin C supplementation in patients with cataract: pilot study", BMC Ophthalmol, 17, pp.121~ (2017)[DOI]